Medical errors: a traceability problem
According to the World Health Organization (WHO), medical errors cause approximately 2.6 million deaths per year in low- and middle-income countries. In developed countries, the Journal of Patient Safety estimates that preventable errors are the third leading cause of death in the United States, with 250,000 to 440,000 annual deaths. Among these errors, patient identification problems and medication errors represent a significant share.
QR codes are emerging as a powerful tool to address these challenges. Their ability to store structured information, combined with the near-universality of smartphones, makes them an effective and low-cost traceability vector.
Patient identification: QR code wristbands
Incorrect patient identification is involved in 86% of medication errors according to the Joint Commission. QR code identification wristbands offer a robust solution: they encode patient data (name, date of birth, medical record number, blood type, known allergies), enable pre-administration verification, and provide timestamped traceability.
Beth Israel Deaconess Medical Center in Boston reported a 50% reduction in medication errors after implementing a dual QR scan system (patient wristband + medication label). The system automatically verifies the "5 rights" of medication administration: right patient, right drug, right dose, right route, right time.
The FDA UDI system: medical device traceability
The FDA deployed the UDI (Unique Device Identification) system requiring every medical device sold in the US to carry a unique identifier as a barcode or QR code. Fully operational since 2020, it covers implants, reusable surgical instruments, in-vitro diagnostic devices, and imaging equipment. In case of product recall, the system can identify in hours all patients carrying a defective implant — a process that previously took weeks.
Drug traceability and anti-counterfeiting
The WHO estimates that 10% of medications in low- and middle-income countries are substandard or falsified. Drug serialization, mandated by the Drug Supply Chain Security Act (DSCSA) in the US and the EU Falsified Medicines Directive, uses QR codes to authenticate each medication box, trace its journey from manufacturer to pharmacy, detect counterfeits, and manage recalls at the serial number level.
Digital vaccination certificates
The EU Digital COVID Certificate (DCC), deployed in June 2021, demonstrated at scale the viability of QR codes as digital health certificates. The system processed over 2.3 billion certificates across 48 countries. The WHO subsequently launched the Global Digital Health Certification Network (GDHCN) in June 2023, building on the DCC experience to create a global framework for digital health certificates covering routine vaccinations, test results, and international prescriptions.
Blood transfusion traceability
Blood product traceability is a life-or-death matter. The ISBT 128 standard is used worldwide for blood product labeling. QR codes are increasingly used to encode blood type, collection and expiration dates, serological test results, and storage temperature history. The American Red Cross processes over 6.8 million blood units per year, and 2D code dual-checking before transfusion has significantly reduced ABO incompatibility risks.
Privacy and GDPR compliance
Using QR codes in healthcare raises important privacy concerns. Health data is classified as sensitive under GDPR Article 9 and requires enhanced protection. QR codes containing medical information must be treated with the same security level as a medical record. Data minimization principles apply: a patient wristband should encode only the medical record number — clinical details remain in the hospital information system. Encryption and informed consent are essential safeguards.